Eli Lilly and Company
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LLY.DE | BMY | BIIB | ABBV.NE | AZN | NVO | |
|---|---|---|---|---|---|---|
| Market cap | 1.05T | 128.04B | 36.96B | 684.50B | 267.53B | 174.34B |
| P/E (TTM) | 46.0 | 13.8 | 44.4 | 206.5 | 25.8 | 9.7 |
| Forward P/E | 165.8 | 9.5 | 15.2 | — | 15.2 | 11.6 |
| Price/book | 34.7 | 5.7 | 2.0 | -19.0 | 5.3 | 5.3 |
| Dividend yield | 0.52% | 4.12% | — | 2.95% | 1.90% | 4.60% |
| 1-year change | +59.60% | +39.45% | +60.57% | +24.96% | +0.99% | −26.62% |
| Today | +4.20% | +2.55% | +3.80% | 0.00% | +2.40% | +1.14% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All LLY.DE news ›RBC Capital Remains a Buy on Eli Lilly & Co (LLY)
The Globe and Mail In a report released yesterday, Trung Huynh from RBC Capital maintained a Buy rating on Eli Lilly & Co, with a price target of $1,500.00. According to TipRanks, Huynh is a 5-star analyst with an average return of 22.0%…
Bristol Myers Squibb vs. Eli Lilly: How Long Can Zepbound and Mounjaro Keep Juicing Revenue Results?
It recently secured expanded regulatory approvals from the U.S. Food and Drug Administration for its targeted cardiovascular treatments, and it separately entered a strategic partnership with Nvidia to deploy advanced artificial…
Eli Lilly and Company LLY:NYSE
Check out Eli Lilly and Company's stock price (LLY) in real time CNBC Eli Lilly and Company LLY:NYSE
Abu Dhabi lures Eli Lilly, Oura, and Whoop in healthcare push
Mubadala Bio signed a deal with US drugmaker Eli Lilly during the Future Health Summit this week to package and distribute GLP-1 drugs locally. Abu Dhabi is betting big on GLP-1 drugs and wearables as it seeks to retool its healthcare…
Analysts’ Opinions Are Mixed on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Eli Lilly & Co (LLY) and Bristol-Myers Squibb (BMY)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioMarin Pharmaceutical (BMRN), Eli Lilly & Co (LLY) and Bristol-Myers Squibb (BMY). Wells Fargo analyst Mohit Bansal assigned a Buy rating to…
Here's What I'm Planning With My Eli Lilly Position
The Globe and Mail Here's What I'm Planning With My Eli Lilly Position Business is booming, and the pipeline of new treatments is robust. Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because…
Mubadala Bio, Eli Lilly lead UAE dealmaking spree in healthcare
circuit.news The UAE has embraced GLP-1 weight-loss drugs and was an early launch market for Eli Lilly’s Mounjaro injector pen following its FDA approval Eli Lilly's Foundayo weight loss pills and Mounjaro injection pen will be packaged in…
Eli Lilly shares weekly forecast: Strong demand for obesity drugs supports sustained gains
Traders Union Eli Lilly shares weekly forecast: Strong demand for obesity drugs supports sustained gains Shares of Eli Lilly and Company (LLY) are trading near $1,286 after climbing about 2% this week, as the recovery holds despite signs…
Eli Lilly, Mubadala Bio sign deal for advance pharma contract manufacturing Abu Dhabi
Eli Lilly and Company (Lilly) and Mubadala Bio have announced a strategic collaboration to advance the localised packaging and logistics of Lilly’s GLP-1 medicines in Abu Dhabi, marking an important step in a shared commitment to advancing…
LLY Stock Alert: What to Know as Eli Lilly Hits a New All-Time High
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com206
-
themarketsdaily.com104
-
tradingview.com86
-
theglobeandmail.com74
-
seekingalpha.com72
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.